BRPI0924041A2 - combination therapies for neoplastic disorders - Google Patents

combination therapies for neoplastic disorders

Info

Publication number: BRPI0924041A2
Authority: BR; Brazil
Prior art keywords: combination therapies; neoplastic disorders; neoplastic; disorders; therapies
Prior art date: 2009-01-08

Application number

BRPI0924041A

Other languages

Portuguese (pt)

Inventor

Caroline B Ho

Christopher B Proffitt

Denis Drygin

Joshua R Bliesath

Kenna Anderes

Sean O' Brien

Original Assignee

Cylene Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-01-08

Filing date

2009-06-10

Publication date

2016-01-26

2009-06-10 Application filed by Cylene Pharmaceuticals Inc filed Critical Cylene Pharmaceuticals Inc

2016-01-26 Publication of BRPI0924041A2 publication Critical patent/BRPI0924041A2/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

BRPI0924041A 2009-01-08 2009-06-10 combination therapies for neoplastic disorders BRPI0924041A2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US14328209P	2009-01-08	2009-01-08
PCT/US2009/046948 WO2010080170A1 (en)	2009-01-08	2009-06-10	Combination therapies for neoplastic disorders

Publications (1)

Publication Number	Publication Date
BRPI0924041A2 true BRPI0924041A2 (en)	2016-01-26

Family

ID=40973134

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0924041A BRPI0924041A2 (en)	2009-01-08	2009-06-10	combination therapies for neoplastic disorders

Country Status (13)

Country	Link
EP (1)	EP2381942A1 (en)
JP (1)	JP2012514638A (en)
KR (1)	KR20110116153A (en)
CN (1)	CN102341107A (en)
AU (1)	AU2009336141A1 (en)
BR (1)	BRPI0924041A2 (en)
CA (1)	CA2749261A1 (en)
IL (1)	IL213969A0 (en)
MX (1)	MX2011007384A (en)
RU (1)	RU2011133093A (en)
SG (1)	SG172922A1 (en)
WO (1)	WO2010080170A1 (en)
ZA (1)	ZA201105755B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20100173013A1 (en) *	2009-01-08	2010-07-08	Denis Drygin	Treatment of neoplastic disorders using combination therapies
CN114869903A (en) *	2022-06-14	2022-08-09	苏天生命科技(苏州)有限公司	Application of bafilomycin A1 in optimization of acute gonorrhea leukemia chemotherapy combination drug

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK2061765T3 (en) *	2006-09-01	2015-01-26	Senhwa Biosciences Inc	Serine-threonine protein kinase AND PARP-MODULATOR
WO2008127707A1 (en) *	2007-04-13	2008-10-23	Dana Farber Cancer Institute, Inc.	Receptor tyrosine kinase profiling

2009
- 2009-06-10 CN CN2009801578849A patent/CN102341107A/en active Pending
- 2009-06-10 AU AU2009336141A patent/AU2009336141A1/en not_active Abandoned
- 2009-06-10 RU RU2011133093/15A patent/RU2011133093A/en not_active Application Discontinuation
- 2009-06-10 MX MX2011007384A patent/MX2011007384A/en not_active Application Discontinuation
- 2009-06-10 CA CA2749261A patent/CA2749261A1/en not_active Abandoned
- 2009-06-10 BR BRPI0924041A patent/BRPI0924041A2/en not_active IP Right Cessation
- 2009-06-10 KR KR1020117018286A patent/KR20110116153A/en not_active Application Discontinuation
- 2009-06-10 SG SG2011050051A patent/SG172922A1/en unknown
- 2009-06-10 EP EP09789791A patent/EP2381942A1/en not_active Withdrawn
- 2009-06-10 JP JP2011545342A patent/JP2012514638A/en not_active Withdrawn
- 2009-06-10 WO PCT/US2009/046948 patent/WO2010080170A1/en active Application Filing
2011
- 2011-07-07 IL IL213969A patent/IL213969A0/en unknown
- 2011-08-04 ZA ZA2011/05755A patent/ZA201105755B/en unknown

Also Published As

Publication number	Publication date
AU2009336141A1 (en)	2011-08-11
SG172922A1 (en)	2011-08-29
WO2010080170A1 (en)	2010-07-15
MX2011007384A (en)	2011-12-14
JP2012514638A (en)	2012-06-28
EP2381942A1 (en)	2011-11-02
KR20110116153A (en)	2011-10-25
ZA201105755B (en)	2012-04-25
CN102341107A (en)	2012-02-01
CA2749261A1 (en)	2010-07-15
RU2011133093A (en)	2013-02-20
IL213969A0 (en)	2011-08-31

Legal Events

Date	Code	Title	Description
2016-09-20	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.
2017-01-10	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI1010868A2 (en)	2018-06-12	gene therapy for neurodegenerative disorders
BR112012011730A2 (en)	2016-03-08	treatments for gastrointestinal disorders
BRPI0909221A2 (en)	2015-08-11	Neurodegenerative disorders
ES1073507Y (en)	2011-03-17	FIXING DEVICE FOR RATES
BRPI1009191A2 (en)	2016-03-01	device for intranasal administration
BRPI0812040A2 (en)	2014-10-21	INDICATIONS FOR ANTI-IL-I-BETA THERAPY
CO6852034A2 (en)	2014-01-30	Enhanced hopper plate assembly
BRPI0924041A2 (en)	2016-01-26	combination therapies for neoplastic disorders
BRPI0909659A2 (en)	2015-09-22	treatment for eye related disorders
ES1074173Y (en)	2011-06-24	PART FOR SOLADOS
ES1075221Y (en)	2011-11-17	VALLADO CORTAVIENTOS FOR THERMOSOLAR PARKS
ES1074376Y (en)	2012-02-08	IMPROVED CRUSHER FOR PRADING REMAINS
ES1065835Y (en)	2008-02-16	CAPETUZA FOR CETRERIA
ES1070148Y (en)	2009-10-16	IMPROVED BARROT MACOLLA
ES1072303Y (en)	2010-09-16	CONNECTION FITTING FOR DRIVES
ES1067107Y (en)	2008-07-16	TRAIN FOR FOOTWEAR
ES1071124Y (en)	2010-04-15	PARAPENT FOR AEROMODELISM
ES1070663Y (en)	2010-01-14	EXCLUSIVE CENICERO FOR C0LILLAS
ES1071628Y (en)	2010-06-15	DISCHARGE MECHANISM FOR CISTERNAS
ES1073423Y (en)	2011-03-14	MASTIL FOR BANDEROLA
ES1075130Y (en)	2011-10-28	THERAPEUTIC ORTHESIS FOR LOWER MEMBER
ES1069850Y (en)	2009-09-14	ARMCHAIR FOR VEHICLES
ES1065263Y (en)	2007-10-16	CAPTAFAROS FOR BIONDA
ES1070740Y (en)	2010-06-25	SELF-IRRIGATION DEVICE FOR MACETS
ES1076121Y (en)	2012-05-08	UNION DEVICE FOR CONSTRUCTION PLATES